---
schema_version: "secwatch.filing_event.v1"
accession: "0000721371-24-000005"
form_type: "8-K"
ticker: "CAH"
cik: "0000721371"
company_name: "CARDINAL HEALTH INC"
filed_at: "2024-01-09T23:59:59+00:00"
generated_at: "2026-06-07T01:43:41.692636+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Cardinal Health raises FY2024 non-GAAP EPS guidance to high end of $6.75–$7.00 on strong cash flow and $250M ASR

## Summary
- Updated FY2024 non-GAAP diluted EPS guidance to high end of $6.75–$7.00.
- Executed $250M accelerated share repurchase in Q2; cash flow strength drove favorability.
- Completed review of at-Home Solutions ($2.6B rev) and OptiFreight Logistics ($250M rev); will invest and develop them.
- New segment structure effective Jan 1, 2024: Pharmaceutical & Specialty Solutions, GMPD, and Other.
- Q2 Medical segment profit expected consistent with Q1, but on track for FY26 target of $650M.

## SEC filing metadata
- accession: 0000721371-24-000005
- form_type: 8-K
- ticker: CAH
- cik: 0000721371
- company_name: CARDINAL HEALTH INC
- filed_at: 2024-01-09T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/721371/000072137124000005/0000721371-24-000005-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/721371/000072137124000005/cah-20240109.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000721371-24-000005
- JSON: https://secwatch.observer/filing/0000721371-24-000005.json
- Plain text: https://secwatch.observer/filing/0000721371-24-000005.txt

## Key facts
- Earnings Releases
  CARDINAL HEALTH INC reported fiscal year 2024 results: EPS high end of $6.75 to $7.00 range. Guidance raised.
  - Period: fiscal year 2024
  - EPS: high end of $6.75 to $7.00 range
  - Guidance: raised
  - Result: guidance update
  source text: Updated fiscal 2024 non-GAAP diluted EPS guidance to high end of $6.75 to $7.00 range
  evidence_url: https://www.sec.gov/Archives/edgar/data/721371/000072137124000005/0000721371-24-000005-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.